Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.1.9
Consolidated Balance Sheets (USD $)
Nov. 30, 2014
Nov. 30, 2013
CURRENT    
Cash and cash equivalents $ 1,085,006us-gaap_CashAndCashEquivalentsAtCarryingValue $ 1,842,149us-gaap_CashAndCashEquivalentsAtCarryingValue
Accounts Receivable 7,393us-gaap_AccountsReceivableNetCurrent 20,351us-gaap_AccountsReceivableNetCurrent
Inventory 120,246us-gaap_InventoryNet 0us-gaap_InventoryNet
Deferred financing costs 170,674us-gaap_DeferredFinanceCostsCurrentNet 0us-gaap_DeferredFinanceCostsCurrentNet
Prepaid expenses and other receivables 29,557us-gaap_PrepaidExpenseAndOtherAssetsCurrent 45,372us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total Current Assets 1,412,876us-gaap_AssetsCurrent 1,907,872us-gaap_AssetsCurrent
Plant and Equipment 144,176us-gaap_PropertyPlantAndEquipmentNet 152,137us-gaap_PropertyPlantAndEquipmentNet
TOTAL ASSETS 1,557,052us-gaap_Assets 2,060,009us-gaap_Assets
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 161,405us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent 106,529us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Total Current Liabilities 161,405us-gaap_LiabilitiesCurrent 106,529us-gaap_LiabilitiesCurrent
Convertible Debentures 1,398,592us-gaap_ConvertibleDebtNoncurrent 0us-gaap_ConvertibleDebtNoncurrent
Total Liabilities 1,559,997us-gaap_Liabilities 106,529us-gaap_Liabilities
STOCKHOLDERS' EQUITY (DEFICIENCY)    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2013 - nil). The provisions in the Articles of Incorporation allow the directors to issue preferred stock with multiple votes per share and dividend rights, which would have priority over any dividends paid with respect to the holders of Company's common stock. 0us-gaap_PreferredStockValue 0us-gaap_PreferredStockValue
Common stock, $0.001 par value 100,000,000 shares authorized, 46,899,285 issued and outstanding (2013: 46,849,285) 46,899us-gaap_CommonStockValue 46,849us-gaap_CommonStockValue
Additional Paid-In Capital 24,024,631us-gaap_AdditionalPaidInCapital 23,226,988us-gaap_AdditionalPaidInCapital
Deficiency (24,042,769)us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage (21,320,357)us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
Accumulated other comprehensive loss (31,706)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax 0us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Total Stockholders' Equity (Deficiency) (2,945)us-gaap_StockholdersEquity 1,953,480us-gaap_StockholdersEquity
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) $ 1,557,052us-gaap_LiabilitiesAndStockholdersEquity $ 2,060,009us-gaap_LiabilitiesAndStockholdersEquity